Coverage of key data relating to the science of inflammatory diseases and new developing therapeutic options that target immune-mediated signalling pathways presented at key congresses and reviewed for your information.
November 10th-14th
Philadelphia
Our review and coverage of ACR 2022 highlights the most relevant data on RA, PsA, and axSpA, and developing therapeutic options with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
June 01-04th
Copenhagen (Hybrid)
Our review and coverage of EULAR 2022 highlights the most relevant data on RA, PsA, and axSpA, and developing therapeutic options with our brochures highlighting key posters and oral presentations ahead of the congress.
View Materials
November 5-9th
Virtual
Our review and coverage of ACR 2021 highlighting the most relevant data on cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways, with our brochures highlighting the key posters and oral presentations ahead of the congress.
View Materials
June 02-05th
Virtual
Our review and coverage of EULAR 2021 highlighting the most relevant data on cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways, with our brochures highlighting the key posters and oral presentations ahead of the congress.
View Materials
August 28-31st
Kyoto(Virtual)
Our review and coverage of APLAR 2021 highlighting the most relevant data on cytokine signalling and new and developing therapeutic options that target cytokine signalling pathways, with our brochures highlighting the key posters and oral presentations ahead of the congress.
View Materials